EGFR Mutational Analysis: Your Key to Personalised Lung Cancer Treatment
Facing a lung cancer diagnosis can feel overwhelming, but knowing your genetic profile gives you power. Our EGFR Mutational Analysis Test provides the critical information your oncologist needs to determine if targeted therapy could offer better outcomes with fewer side effects than traditional chemotherapy.
Understanding Your EGFR Mutation Status
EGFR (Epidermal Growth Factor Receptor) mutations are specific genetic changes found in some lung cancers. When these mutations are present, targeted medications can precisely attack cancer cells while sparing healthy tissue. Our test analyses your tumor tissue to identify these mutations, helping your medical team choose the most effective treatment approach from the start.
Using advanced PCR and sequencing technology, we achieve 99% accuracy in detecting EGFR mutations, ensuring your treatment decisions are based on reliable genetic information.
Who Should Consider This Test?
This test is particularly important if you:
- Have been diagnosed with non-small cell lung cancer (NSCLC)
- Are considering first-line treatment options
- Have adenocarcinoma subtype of lung cancer
- Are a non-smoker or light smoker with lung cancer
- Want to explore targeted therapy alternatives to chemotherapy
- Need to determine eligibility for specific cancer medications
Early genetic testing can significantly impact your treatment success and quality of life during cancer care.
Why This Test Matters for Your Health Journey
Knowing your EGFR status provides several crucial benefits:
- Personalised Treatment: Identifies if you’re likely to respond to targeted EGFR inhibitors
- Reduced Side Effects: Targeted therapies often have fewer side effects than chemotherapy
- Better Outcomes: Patients with EGFR mutations typically respond better to targeted treatments
- Informed Decisions: Gives you and your oncologist confidence in treatment choices
- Peace of Mind: Reduces uncertainty about which treatment path to follow
Understanding Your Test Results
Your results will clearly indicate whether EGFR mutations were detected in your tumor sample. If mutations are found, your oncologist can prescribe targeted medications specifically designed to block the abnormal signals driving your cancer’s growth. If no mutations are detected, your medical team can confidently pursue other effective treatment options without delay.
Our comprehensive report includes easy-to-understand explanations and is delivered directly to your oncologist within 3-5 days of sample receipt.
Transparent Pricing – Exceptional Value
| Test Description | Regular Price | Special Price | Savings |
|---|---|---|---|
| EGFR Mutational Analysis | R3,350 | R1,650 (33% off) |
This investment in precise genetic testing could save thousands in ineffective treatments and provide priceless peace of mind.
Why Trust Oracle Genomics?
- Nationwide Coverage: Accessible testing across South Africa including Johannesburg, Cape Town, Durban, and Pretoria
- Medical Expertise: Tests supervised by qualified oncologists and genetic specialists
- Fast Turnaround: Samples processed Monday/Thursday by 9am with reports Friday/Tuesday
- Accredited Laboratory: Stringent quality controls ensuring 99% accuracy
- Patient-Focused: Empathetic support throughout your testing journey
Sample Requirements
To ensure accurate results, please provide:
- Formalin fixed paraffin embedded block containing tumor tissue
- Paraffin block must contain minimum 10% tumor cells
- Ship at room temperature
- Copy of Histopathology report
- Duly filled NGS Test Requisition Form (Form 40) – mandatory
Take Control of Your Cancer Treatment Today
Don’t leave your treatment decisions to chance. Knowing your EGFR status could be the difference between standard chemotherapy and a more targeted, effective approach with fewer side effects.
Limited Time Offer: Save R1,650 on this essential genetic test. Early detection of treatable mutations can significantly improve your treatment outcomes and quality of life.
“The EGFR test gave us clarity when we needed it most. Knowing my mother’s mutation status helped her avoid unnecessary chemotherapy and start targeted treatment immediately.” – Recent Patient Family
